Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Deficit

v3.22.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Retained Earnings
Previously Reported
Previously Reported
Common Stock
Previously Reported
Additional Paid-in Capital
Previously Reported
AOCI Attributable to Parent
Previously Reported
Retained Earnings
Revision of Prior Period, Adjustment
Revision of Prior Period, Adjustment
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Revision of Prior Period, Adjustment
AOCI Attributable to Parent
Revision of Prior Period, Adjustment
Retained Earnings
Beginning balance at Dec. 31, 2019 $ 763,815         $ 763,815         $ 0        
Beginning balance (in shares) at Dec. 31, 2019 290,425,630         133,784,888         156,640,742        
Ending balance at Dec. 31, 2020 $ 763,283                            
Ending balance (in shares) at Dec. 31, 2020 290,300,547                            
Beginning balance (in shares) at Dec. 31, 2019   263,572,316         121,414,839         142,157,477      
Beginning balance at Dec. 31, 2019 $ (82,225) $ 3 $ 38,961 $ 125 $ (121,314) $ (82,225) $ 0 $ 38,964 $ 125 $ (121,314) $ 3 $ (3) $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options (in shares)   3,433,498                          
Issuance of common stock upon exercise of stock options 2,952   2,952                        
Vesting of early exercised stock options 388   388                        
Vesting of early exercised stock options (in shares)   2,262,645                          
Vesting of restricted stock (in shares)   9,542,168                          
Stock-based compensation 16,880   16,880                        
Unrealized loss on held for sale investments (125)     (125)                      
Net loss (214,449)       (214,449)                    
Ending balance (in shares) at Dec. 31, 2020   278,810,627                          
Ending balance at Dec. 31, 2020 (276,579) $ 3 59,181 0 (335,763)                    
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Repurchase of series B redeemable convertible preferred stock at $4.26 $ (532)                            
Repurchase of series B redeemable convertible preferred stock at $9.2403 (in shares) (125,083)                            
Issuance of series U-1 redeemable convertible preferred stock at $9.06 per share in relation to acquisition $ 1,000,000                            
Issuance of series U-1 redeemable convertible preferred stock at $19.66 per share in relation to acquisition (in shares) 110,437,359                            
Issuance of series U-2 redeemable convertible preferred stock at $9.06 per share, net of issuance costs of $2,138 $ 397,862                            
Issuance of series U-2 redeemable convertible preferred stock at $19.66 per share, net of issuance costs of $2,138 (in shares) 44,174,944                            
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (2,161,145)                            
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) (444,912,850)                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock in relation to acquisitions $ 937,668 $ 3 937,665                        
Issuance of common stock in relation to acquisitions (in shares)   257,863,127                          
Purchase consideration allocated to non-cash compensation expense 7,873   7,873                        
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)   444,912,850                          
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization 2,161,145 $ 4 2,161,141                        
Issuance of common stock upon the reverse recapitalization, net of issuance costs 1,040,521 $ 1 1,040,520                        
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)   129,294,175                          
Issuance of common stock upon exercise of stock options (in shares)   8,393,301                          
Issuance of common stock upon exercise of stock options 7,847   7,847                        
Issuance of common stock upon vesting of restricted stock units (in shares)   917,959                          
Common stock withheld for net share settlement of equity awards (in shares)   (302,418)                          
Common stock withheld for net share settlement of equity awards (3,705)   (3,705)                        
Vesting of early exercised stock options 182   182                        
Vesting of early exercised stock options (in shares)   1,271,075                          
Vesting of restricted stock (in shares)   1,669,118                          
Stock-based compensation 222,203   222,203                        
Unrealized loss on held for sale investments 0                            
Net loss (755,453)       (755,453)                    
Ending balance (in shares) at Dec. 31, 2021   1,122,829,814                          
Ending balance at Dec. 31, 2021 $ 3,341,702 $ 11 $ 4,432,907 $ 0 $ (1,091,216)